ASCENDED SOLUTIONS LTD
Company number 12932367 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
ASCENDED SOLUTIONS LTD - Analysis Report
Company Number: 12932367
Analysis Date: 2025-07-20 14:00 UTC
Financial Health Assessment for Ascended Solutions Ltd as of 31 December 2023
1. Financial Health Score: D
Explanation:
Ascended Solutions Ltd exhibits concerning financial indicators, notably a negative net current asset position and shareholders' funds deficit in the latest financial year. These suggest symptoms of financial distress and weakened capital structure, warranting a cautious outlook. The company’s liquidity and solvency have deteriorated significantly compared to prior years.
2. Key Vital Signs
| Metric | 2023 Value (£) | Interpretation |
|---|---|---|
| Current Assets | 2,557 | Drastically reduced from £10,269 in 2022, indicating shrinking liquid resources and receivables. |
| Cash | 2,040 | Slightly increased from prior year, showing some cash retention. |
| Debtors | 517 | Substantial drop from £8,315 in 2022, possibly reflecting reduced sales or better collections. |
| Current Liabilities | 3,030 | Decreased from £4,099 in 2022 but still exceeds current assets, indicating inability to meet short-term obligations from liquid assets alone. |
| Net Current Assets | (473) | Negative working capital, a classic symptom of liquidity stress. |
| Shareholders’ Funds | (473) | Negative equity, reflecting accumulated losses or withdrawals exceeding capital. |
| Fixed Assets | 0 | Disposal of all tangible assets in 2023, possibly to raise cash or reduce overheads. |
3. Diagnosis
The company’s financial vital signs reveal a shift from a previously healthy liquidity and equity position in 2021-2022 to a state resembling financial illness in 2023. The negative net current assets indicate an inability to cover short-term debts with available current assets—a symptom of liquidity distress that can impair operational capability.
The negative shareholders' funds signal an erosion of the company’s capital base, possibly due to losses incurred or director loans being repaid/removed (noted by the £3,030 director creditor balance). The disposal of tangible fixed assets further points to a defensive move to bolster cash, which may be a response to ongoing financial strain.
Overall, these symptoms suggest the company is struggling to maintain financial health and may face challenges meeting obligations without new capital injection, improved revenue, or cost restructuring.
4. Recommendations
- Cash Flow Management: Closely monitor cash inflows and outflows. Establish a rolling cash flow forecast to anticipate shortfalls and plan accordingly.
- Debt Restructuring: Engage with creditors, especially director loans, to negotiate payment terms or consider formal restructuring to alleviate immediate liquidity pressure.
- Capital Injection: Consider equity funding or shareholder loans to restore positive working capital and bolster shareholders' funds.
- Revenue Enhancement: Investigate causes of debtor reduction—whether due to lost sales or improved collections—and implement strategies to increase turnover sustainably.
- Cost Control: Review all operational expenses, including overheads, and identify areas for cost reduction without compromising business viability.
- Asset Utilization: Since fixed assets were disposed of, ensure that key operational assets are adequately replaced or that outsourcing is cost-effective.
- Professional Advice: Seek advice from insolvency or restructuring professionals if liquidity issues persist or worsen.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.